Chisato Takahashi

Dr. Chisato Takahashi

Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kyōto, Japan
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2021 in Science Advances
Verified
Journal Article
Open access
YOYukako Oda
Yukako Oda
CTChisato Takahashi
Chisato Takahashi
SHShota Harada
Shota Harada
SNShun Nakamura
Shun Nakamura
DSDaxiao Sun
Daxiao Sun
FTFumiko Toyoshima
Fumiko Toyoshima
C-terminal alpha 1-antitrypsin peptides induce tight junction formation by activating G protein G13.

Verified
Journal Article
Open access
PDF file
CTChisato Takahashi
Chisato Takahashi
MOMariko Oishi
Mariko Oishi
YIYuko Iwata
Yuko Iwata
KMKeiko Maekawa
Keiko Maekawa
TMTsuyoshi Matsumura
Tsuyoshi Matsumura
Cardiomyopathy is the leading cause of death in patients with muscular dystrophy (MD). Tranilast, a widely used anti-allergic drug, has displayed inhibitory activity against the transient receptor potential cation channel subfamily V member 2 and improved cardiac function in MD patients. To identify urinary biomarkers that assess improved cardiac function after tranilast administration, we performed a urinary metabolomic study focused on oxidative fatty acids. Accompanying the clinical trial of tranilast, urine specimens were collected over 24 weeks from MD patients with advanced heart failure. Urinary levels of tetranor-PGDM (tetranor-prostaglandin D metabolite), a metabolite of prostaglandin D2, significantly decreased 12 weeks after tranilast administration and were correlated with BNP. These results suggest that prostaglandin-mediated inflammation, which increases with the pathological progression of heart failure in MD patients, was attenuated. Urinary prostaglandin E3 (PGE3) levels significantly increased 4 weeks after tranilast administration. There were positive correlations between the urinary levels of PGE3 and 8-hydroxy-2′-deoxyguanosine, an oxidative stress marker. High PGE3 levels may have a protective effect against cardiomyopathy in MD patients with high oxidative stress. Although further validation studies are necessary, urinary tetranor-PGDM and PGE3 levels may help the current understanding of the extent of advanced heart failure in patients with MD after tranilast administration.

9 December 2023 in Journal of AOAC INTERNATIONAL
Verified
Journal Article
Closed access
PDF file
KMKeiko Maekawa
Keiko Maekawa
RSRyuichi Sawa
Ryuichi Sawa
MMMari Matsui
Mari Matsui
TKToshifumi Konda
Toshifumi Konda
YKYumiko Kubota
Yumiko Kubota
SSSatowa Suzuki
Satowa Suzuki
Through the recent development of analytical technology, antibiotics quantification in the Japanese Pharmacopoeia (JP) has changed from traditional microbiological assays to physicochemical methods with high specificity and precision. However, for several multicomponent antibiotics without typical UV absorption, potency cannot be directly determined using instrumental methods such as high-performance liquid chromatography; therefore, traditional microbiological assays are still used. Gentamicin sulfate (GmS), which consists of three major components, C1, C1a, and C2, is such a typical antibiotic, and its antimicrobial potency continues to be assayed using microbiological methods in JP monographs. Introduction of physicochemical assay for GmS is needed to help ensure its quality and quantity. This study aimed to develop quality control measures for GmS that could be complimentary to quantitative assays and purity tests specified in the JP. For each gentamicin C component (C1, C2, and C1a), theoretical potencies were determined based on the quantitative relationship between purity and potency, as measured by quantitative 1H NMR and microbiological assays, respectively. Two lots of the JP reference standard (RS) were used as test samples, with the contents of each component and impurity (sisomicin and garamine) being determined using hydrophilic interaction liquid chromatography-tandem mass spectrometry (HILIC-MS/MS). The ratios of theoretical potency for C1, C2, and C1a were 1.00, 1.21, and 1.80, respectively. The potencies of the GmS JP RSs, which were estimated based on the contents and theoretical potency of each C component, corresponded well with those determined through microbiological assays. Marked differences in impurities (%) between the two RS lots were highlighted by quantifying sisomicin and garamine. The developed analytical procedure enabled the characterization of two different JP RSs in terms of content ratio, potencies, and impurities. Novel analytical procedures useful for routine quality control of GmS were developed using HILIC-MS/MS.

20 September 2016
Verified
Book Chapter
Closed access
PDF file
CTChisato Takahashi
Chisato Takahashi
TNTomomi Nonaka
Tomomi Nonaka
MNMasaru Nakano
Masaru Nakano